CRISPR-mediated gene editing is a versatile technology with an unprecedented potential to transform many areas of life science. It’s no surprise that CRISPR technology won the Noble Prize in Chemistry in 2020 and continues to find new applications – from treating genetic diseases to ensuring food security.
Compared with other technologies, genome editing using the CRISPR-Cas9 system is affordable and straightforward, but there are still challenges to overcome. For example, inefficiencies in editing can make it cumbersome to characterize gene edits.
At QIAGEN, our technologies and dedicated workflows make it quicker and easier to create (clone), characterize and analyze gene editing events.
Check out the workflow-specific tabs above to learn more.